Photocure | Sustainability Performance
Photocure is engaged in pharmaceutical development, with a focus on products for the treatment of bladder cancer. The company aims to advance patient care through innovative therapies while emphasizing safety and efficacy in its product offerings.
1993
Norway
51 - 200 employees
Pharmaceuticals
$25M - 100M in revenue
$0 - 100K in profitability
Sustainability Ranking & Industry Benchmark
#8150
Overall#159
in Norway#191
in PharmaceuticalsSustainability Maturity
Sustainability Intent
Overview
Controversy level
- Photocure's marketing of Hexvix for bladder cancer detection was scrutinized for claims about diagnostic accuracy improvements.
